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A new rat model of creatine 
transporter deficiency reveals 
behavioral disorder and altered 
brain metabolism
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Creatine is an organic compound used as fast phosphate energy buffer to recycle ATP, important 
in tissues with high energy demand such as muscle or brain. Creatine is taken from the diet or 
endogenously synthetized by the enzymes AGAT and GAMT, and specifically taken up by the 
transporter SLC6A8. Deficit in the endogenous synthesis or in the transport leads to Cerebral Creatine 
Deficiency Syndromes (CCDS). CCDS are characterized by brain creatine deficiency, intellectual 
disability with severe speech delay, behavioral troubles such as attention deficits and/or autistic 
features, and epilepsy. Among CCDS, the X‑linked creatine transporter deficiency (CTD) is the most 
prevalent with no efficient treatment so far. Different mouse models of CTD were generated by 
doing long deletions in the Slc6a8 gene showing reduced brain creatine and cognitive deficiencies or 
impaired motor function. We present a new knock‑in (KI) rat model of CTD holding an identical point 
mutation found in patients with reported lack of transporter activity. KI males showed brain creatine 
deficiency, increased urinary creatine/creatinine ratio, cognitive deficits and autistic‑like traits. The 
Slc6a8Y389C KI rat fairly enriches the spectrum of CTD models and provides new data about the 
pathology, being the first animal model of CTD carrying a point mutation.
Creatine (Cr) is a nitrogenous organic acid used as phosphate energy buffer to recycle ATP by the Cr-PCr 
system; Cr is also one of the main osmolytes of the brain, and suggested to play a role as neuromodulator or 
 neurotransmitter1,2. Cr is taken from the diet or endogenously synthetized in a two-step pathway by the enzymes 
AGAT (arginine-glycine amidinotransferase) and GAMT (guanidinoacetate methyltransferase), and specifically 
transported into the cells by SLC6A8 (also called CRT, CreaT or CT1, henceforth CrT)2. Guanidinoacetate (GAA) 
is synthetized from arginine (Arg) and glycine (Gly) in the first step, and it is methylated generating Cr in the 
second step. Cr breaks down spontaneously in creatinine (Crn).
Deficits in endogenous synthesis or transport of Cr cause Cerebral Creatine Deficiency Syndromes (CCDS)3–6. 
CCDS are characterized by brain Cr deficiency, intellectual disability with severe speech delay, behavioral abnor-
malities such as attention deficits and/or autistic features, and seizures for GAMT and SLC6A8  deficiencies7. 
Among CCDS, Cr transporter deficiency (CTD) is caused by loss-of-function mutations in the SLC6A8 gene (for 
a scheme of the human locus with the position of the mutations, see Fig. 1A). CTD is a X-linked gene disorder 
with an estimated prevalence of about 2% of males with intellectual disability with, unlike the other two CCDS, 
no efficient treatment so  far1,7,8. CTD is currently diagnosed by 1H-MRS, urine analysis and genetic  sequencing7. 
1H-MRS evaluates whether Cr is deficient in the brain, the common feature in all CCDS; urine analysis tests for 
the specific biochemical marker of CTD (increased urinary Cr/Crn ratio).
To better understand the pathology and with the ultimate goal of finding a treatment, several mouse models 
for CTD have been  generated9–16. In particular, CrT knock-out (KO) mouse males with ubiquitous deletions of 
the exons 2–49,16 or 5–712–14 showed brain creatine deficiency and decreased body weight, features present in CTD 
 patients17. Ubiquitous CrT KO males with exons 5–7 deleted also showed impaired motor  function12. Cognitive 
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deficits with normal sociability were demonstrated in the ubiquitous KO males with deletions in exons 2–49,16 
and 5–713,14. Deletion in exons 2–4 also caused some changes in monoamine neurotransmitters correlating with 
higher resilience to stress, while deletion in exons 5–7 leaded to more stereotypies, impaired working memory 
performance and some brain alterations associated with aging. Interestingly, while ubiquitous deletion of the 
exons 2–4 after tamoxifen induction in neonatal and adult mice led to brain Cr deficiency and lower body weight, 
cognitive deficits were only present if the induction was during the neonatal period highlighting the important 
role of Cr during brain  development10.
Brain-specific KO mice of CrT have shown additional and somehow different phenotypes. Deletion of exons 
2–411 or 5–713,18 in CNS nestin-positive cells exhibited brain Cr deficiency but normal Cr levels in periphery. 
Brain CrT KO of exons 2–4 mice maintained the same learning and memory deficits as the corresponding 
ubiquitous KO, plus hyperactivity and normal body  weight11. In contrast, brain CrT KO of exons 5–7 mice 
showed a rescue in the general phenotype (no stereotypies, normal memory performance and body weight) but 
declined at early age, correlating with some brain alterations related with  aging13,18. Deletion of CrT exons 2–4 
Figure 1.  Generation and genotyping of Slc6a8Y389C rat. (A) Scheme of human SLC6A8 locus with the 
exons and the position of mutations found in patients (vertical red bars; missense mutations or little deletions 
according to Van de Kamp et al. 2013). Black arrow points to the position of the mutation c.1166A > G. (B) 
Wild-type rat cDNA sequence showing the alternating exons (black and blue letters) and the position of the 
mutation (red highlight). Green and orange backgrounds represent WT and KI fragments, respectively, after 
PCR amplification. Underlined letters are the sequences related to the primers used. (C) PCR products for each 
genotype. WT fragment at the left, KI at the right.
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in CaMKII-positive cells (excitatory neurons)15 revealed similar phenotype as the nestin-targeted KO mouse, 
while targeting only DAT-positive cells (dopaminergic neurons) exhibited  hyperactivity19.
All the accumulating knowledge using these various mouse models highlights the importance of the Cr 
transporter in brain function and physiology, and allows a better understanding of SLC6A8 deficiency. However, 
CTD patients do not always present the same  phenotype17. Further studies are thus needed to fully understand 
CTD pathology, and to allow, through the use of various complementary animal models, the best translation to 
human  pathology20.
As an alternative to mouse models, rats have a number of potential advantages over mice. In particular, they 
are closer to human physiology, biochemistry and behavior in comparison with  mice21,22. In order to increase 
the fundamental knowledge and to increase the relevance of preclinical studies with complementary preclinical 
models, we generated a novel rat model of CTD: the Slc6a8Y389C knock-in (KI) rat line. Slc6a8Y389C KI rat holds a 
point mutation found in CTD patients which was reported to completely abolish Cr transporter  activity7. Here 
we show the first analysis of Slc6a8xY389C/y rat KI males as model of CTD, being the first KI animal model of CTD.
Methods
Generation, genotyping and housing of the Slc6a8Y389C KI rat strain. Based on the patient SLC6A8 
c.1166A > G; p.(Tyr389Cys) point missense mutation reported as completely abolishing Cr transporter  activity17 
(Fig. 1A), we designed a KI Slc6a8 c.1166A > G; p.(Tyr389Cys) rat line (henceforth Slc6a8Y389C, Fig. 1B). As in 
human, the rat Slc6a8 gene is located on the X chromosome, thus 3 Slc6a8xY389C/y male (KI) and 3 heterozygous 
Slc6a8xY389C/x female founders were generated from the Sprague–Dawley (OFA-SD) rat strain using CRISPR/
Cas9 technology (Cyagen Biosciences Inc, USA; see details in Supplementary materials). Slc6a8Y389C rats were 
viable and fertile, and crossbreedings between wild-type males (WT) or KI males and wild type females or 
heterozygous females generated litters with the expected Mendelian ratios and with the 5 possible genotypes: 
(WT and Slc6a8xY389C/y KI males; WT, heterozygous Slc6a8xY389C/x and homozygous Slc6a8xY389C/xY389C females; 
Fig.  1C). For the present study, crossbreedings between WT males and heterozygous females were made to 
obtain WT and Slc6a8xY389C/y KI males in the same litter.
Genotyping was standardized using PCR amplification (QIAGEN kit ref. 201445). DNA was obtained from ear 
punch using the KAPA BIOSYSTEMS kit (ref. KK7352) and finally diluted in nuclease-free water. Amplification 
primers were: for WT fragment (250 bp) F-WT/5′-GGT CTA GCC TTC ATT GCC TA-3′ and R-WT/5′-GCC CTC 
CAC ACC TAC AAA CT-3′; for KI fragment (211 bp) F-KI/5′-ACT CTG GCA TGA GAC CCT GT-3′ and R-KI/5′-
CAG TGT GAC AGC CCG TGG GC-3′. PCR conditions were as follows: 10 min 94 °C, 2x[30 s 94ºC, 30 s 67 °C, 
30 s 72 °C], 36x[30 s 94 °C, 30 s 66 °C, 30 s 72 °C], 10 min 72 °C, store at 4 °C. A representative PCR of the 5 
possible genotypes is shown in Fig. 1C.
Animals were maintained under a 12 h/12 h light–dark cycle. Food and water were available ad libitum. All 
experiments were performed with the approval of the veterinary authorities of the Canton de Vaud (Switzerland; 
authorization VD-3284) and in accordance with the regulations of the Swiss Academy of Medical Science, as 
well as followed the ARRIVE Guidelines 2.0. Efforts were made to minimize stress and number of animals used.
Proton magnetic resonance spectroscopy (1H‑MRS) in CNS at high magnetic field (9.4 T). For 
1H-MRS 3 months-old rats were anesthetized with isoflurane (4% during induction; 2% for maintenance) using 
a nose mask under 70% compressed air and 30%  O2. Body temperature (kept at 37.5 ± 1.0 °C using circulating 
warm water) and respiration were monitored continuously by a small-animal monitor system (SA Instruments, 
New York, USA). In vivo 1H-MRS was performed on a horizontal actively shielded 9.4 T system (Magnex Sci-
entific, Oxford, UK) interfaced to a Varian Direct Drive console (Palo Alto, USA). A home built 1H-quadrature 
surface coil (14 mm diameter) was used as transceiver and placed over the head of the animal. The volumes of 
interest (VOI) were positioned in dorsal hippocampus (2 × 2.8 × 2  mm3, 4 WT and 5 KI), striatum (2.5 × 2 × 2.5 
 mm3, 4 WT and 5 KI) and cerebellum (2.5 × 2.5 × 2.5  mm3, 3 WT and 4 KI) using axial and sagittal anatomical  T2 
weighted images (multislice turbo-spin-echo sequence, repetition time TR = 4 s, effective echo time  TEeff = 52 ms, 
echo train length = 8, field of view = 23 × 23  mm2, slice thickness = 1 mm, 2 averages, 256 × 256 image matrix). The 
static magnetic field homogeneity was adjusted using first and second order shims by FAST(EST)MAP leading 
to water linewidths of 10–12 Hz for hippocampus and striatum and 14–16 Hz for  cerebellum23. Localized spectra 
were acquired with SPECIAL spectroscopy sequence (TE = 2.8 ms, TR = 4 s, 160 averages) to obtain the specific 
neurochemical profile in the 3 mentioned  VOIs24,25. Metabolite concentrations were estimated using LCModel 
 software26 and water as internal reference. The LCModel basis-set for spectral fitting contained a spectrum of 
macromolecules acquired in vivo27 and 17 individual metabolites measured in vitro: alanine (Ala), ascorbate 
(Asc), aspartate (Asp), glycerophosphocholine (GPC), phosphocholine (PCho), creatine (Cr), phosphocreatine 
(PCr), γ-aminobutyrate (GABA), glutamine (Gln), glutamate (Glu), glutathione (GSH), myo-inositol (Ins), 
lactate (Lac), N-acetylaspartate (NAA), N-acetylaspartylglutamate (NAAG), phosphoethanolamine (PE) and 
taurine (Tau). PCho and GPC were expressed as tCho (PCho + GPC) due to better accuracy in the estimation of 
their concentration as a sum. The ultra-short echo-time 1H-MRS allowed the detection of the abovementioned 
17  metabolites24.
CSF, urine and plasma collection. The same day of the sacrifices, 6 WT and 7 KI rats aged of 3 months 
were anesthetized with 4% isoflurane under 70% compressed air and 30% O2. Fur around the base of the head 
and the dorsal part of the neck was shaved with an electric shaver. A little incision was made in medial position 
and longitudinally through the skin and muscles at the base of the skull. The cavity was maintained opened using 
little separators and cleaned of blood using cotton swabs. Carefully, puncture in cisterna magna was made to 
collect CSF. After CSF collection, the rat was positioned in supine position and the abdominal cavity was opened 
4
Vol:.(1234567890)
Scientific Reports |         (2021) 11:1636  | https://doi.org/10.1038/s41598-020-80824-x
www.nature.com/scientificreports/
to collect urine from the bladder. Finally, the thoracic cavity was opened and blood was collected transcardially 
with heparin (5000 u/ml) and centrifuged at 2710 × g for 7 min. Supernatant (plasma) was transferred in a new 
tube. Liquids (CSF, urine and plasma) were stored at – 80 °C for further analysis.
Measure of creatine, guanidinoacetate and creatinine in plasma, urine and CSF. Cr and GAA 
were quantified by liquid chromatography coupled to mass spectrometry (LC–MS) following a µSPE sam-
ple preparation protocol. For plasma and urine, 180  µl of a 0.28  µM aqueous solution of internal standards 
 (d3-Creatine, Sigma-Aldrich and 13C2-Guanidino acetic acid, VU Medical Center Amsterdam) containing 2.2% 
formic acid (v/v) was added to 20 µl of centrifuged plasma or urine. For CSF, 100 µl of 0.5 µM internal standard 
solution was mixed with 100 µl of CSF sample. The samples were loaded on a MCX µSPE plate (Oasis MCX 
µElution Plate 30 µm, Waters Corp.) previously activated with MeOH and water, and then washed with formic 
acid 2% (v/v) and MeOH. Elution was obtained with 0.67 mol/l  NH4OH solution on collection wells prefilled 
with acetonitrile. After centrifugation, samples were directly injected onto a LC–MS system (Waters I-Class 
UPLC system coupled with a Waters XEVO TQS micro mass spectrometer). Separation of the analytes was per-
formed in a 4.5 min gradient at a flow rate of 0.5 ml/min on a HILIC column (ACQUITY UPLC BEH HILIC, 
2.1 × 100 mm, 1.7 µm, Waters Corp.) maintained at 30 °C, with a 0.2% formic acid containing ammonium formi-
ate (10 mmol/l):acetonitrile mobile phase gradient. Mass spectrometry was performed by electrospray ioniza-
tion in positive mode using two SRM (Selected Reaction Monitoring) transitions (one quantifier and one quali-
fier) for each analyte. The m/z values of the selected quantitative and qualitative transitions, respectively, were 
the following: 118 → 100.85 and 118 → 30 for GAA, 120 → 103 and 120 → 31 for 13C2-GAA, 132.1 → 43.82 and 
132.1 → 90 for Cr, 135 → 46.88 and 135 → 93 for d3-Cr. Quantified concentrations were calculated with Target-
Lynx (Waters Corp.). Creatinine (Crn) was measured in urine by a COBAS 8000 automate (Roche, Switzerland).
Behavioral tests. Two cohorts of males were used to do the behavioral tests: grooming and Y-maze for 
spatial memory test in one; novel object recognition (NOR), Y-maze for spontaneous alternation and Social 
preference/Social memory (SP-SM) tests for the other one. Each cohort contained 3 to 4 litters in which WT and 
KI were littermates between them. The set of tests began at 12 weeks of age.
Grooming. Rats were introduced in a round (1 m diameter) open arena with black walls and floor made of 
black PVC for 10 min while spontaneous behavior was recorded with a videocamera. Grooming behavior was 
hand-scored blindly with the Observer XT software and cumulative duration and frequency of such behavior 
were analyzed. 10 WT and 10 KI males were used.
Y‑maze for spatial memory test. A Y-shape maze of 50 cm arm length, grey walls and floor made of grey PVC in 
conditions of 4 lx in each arm was used. For the learning phase, the rat was introduced in the Y-maze for 10 min 
with one arm closed. After 4 h, the rat was located in the same starting arm and was allowed to explore all the 
arms for 5 min. EthoVision tracking software was used to track the time spent in each arm. Exploration time 
(tN + tF, in seconds) and Recognition Index ((tN—tF)/(tN + tF)) were calculated from the cumulative time spent 
in the familiar (tF) and the new (tN) arms. 9 animals per group were used.
Novel object recognition (NOR) test. An arena of 57 × 36 cm with grey walls and floor made of grey PVC in 
4 lx conditions was used. For habituation, the rat explored the empty arena for 5 min. On next day, the rat was 
introduced in the arena with two identical objects for 5 min in the learning phase. After 4 h, the rat was allowed 
to explore again the arena for 5 min but one of the objects was changed for a different one. Both, new and famil-
iar objects and the right and the left sides were randomized. All phases were recorded with a videocamera and 
exploratory behavior was hand-scored blindly with the Observer XT software. The cumulative duration times 
for exploring familiar (tF) and new object (tN) in testing phase were used to calculate Exploration Time (in sec-
onds, tN + tF) and Recognition Index ((tN − tF)/(tN + tF)). 8 WT and 9 KI males were used.
Y‑maze spontaneous alternation. The rat was introduced in the abovementioned Y-maze and allowed to explore 
the three arms opened for 8 min. EthoVision tracking software was used to track rat position and calculate the 
number of total entries in all the arms (nº entries in arm A + arm B + arm C) as well as the percentage of alterna-
tion (100 * frequency of alternations/(nº total entries − 2)). 8 WT and 10 KI males were used.
Social preference and social memory (SP‑SM) tests. A three-chamber arena 80 × 34  cm with grey walls and 
floor made of grey PVC with 10 lx in the center was used for SP-SM test. A transparent cylinder made of PVC, 
13 cm in diameter and with openings, was positioned in each lateral chamber. During habituation, a juvenile 
rat was located in one cylinder while an object was positioned in the other one, and the experimental male 
rat was allowed to explore only the center chamber for 5 min. During the social preference phase, doors were 
opened and the rat could explore all the chambers (with the juvenile rat or the object) for 10 min. After 2 h, the 
object was changed for another juvenile, and the experimental rat was allowed to explore both new and familiar 
juveniles for 10 min. Relative positions of the items (object and juveniles) were randomized. All phases were 
recorded with a videocamera and exploration behavior towards the object or the juveniles was hand-scored 
blindly with the Observer XT. Cumulative duration time exploring each item, the number of visits (frequency) 
per each item, and the first item to be explored in each phase were taken into account for the analysis. 9 WT and 
10 KI were used.
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Statistical analysis and graphs. All statistical analysis and graphs were conducted with R-3.5.128. A Sha-
piro test was used to assess the normality of each sample. To address the significance between WT and KI groups 
or between each group with respect to the value expected by chance, Mann–Whitney tests were performed when 
normality was rejected while, for normal distributions, we used Bartlett tests to evaluate equality of variances 
and t-tests for equality of the means. Potential influence of litter variability was considered and discarded after 
conducting linear mixed-effect tests in which litter factor was modelled as a random effect (package  lme429).
To calculate the  log10 of the ratio KI/WT concentrations of different metabolites in brain, a pseudocount 
(+ 0.001) was added to all concentrations before doing the ratio. Graphs were done using ggplot2  package30, 
while heatmaps were generated with  gplots31.
In the analysis of first decision for the SP-SM experiment, we evaluated different questions. First, we asked if 
there was a significant bias in the decision of exploring first one of the two possibilities. We modelled this question 
considering a Bernouilli variable with probability q = 0.5 (no preference), and estimating the probability of select-
ing one of the two choices with a binomial distribution of parameters q, N, k, where N is the number of animals 
tested and k the number of visits of one of the items. We tested if the preferred choice was significantly different 
than random performing a two-tail exact binomial test, or a one-tail exact binomial test when prior informa-
tion existed (e.g. when a given behavior was observed for the WT and the preference of the KI was tested, or 
when the preference was known a priori from literature). Finally, we tested if the preferences of KI and WT were 
significantly different between them using a Barnard’s CSM Test (exact.test, method = CSM, package  Exact32).
Results
Generation of the Slc6a8Y389C rat. To obtain a model as near as possible of the human CTD, a knock-in 
(KI) rat was generated with the SLC6A8 c.1166A > G; p.(Tyr389Cys) missense mutation found in human patients 
and reported with no functional activity of the  transporter17 (Fig. 1). The obtained Slc6a8Y389C rats were viable 
and bred normally, generating litters with the expected Mendelian ratios.
Slc6a8Y389C rats are deficient in brain Cr. CTD patients are characterized by CNS Cr deficiency and are 
diagnosed, as all CCDS patients, using brain 1H-MRS. High magnetic field 9.4 T 1H-MRS spectra in hippocam-
pus (Fig. 2A) as well as other brain regions (striatum, cerebellum; data not shown) systematically showed much 
lower peaks corresponding to Cr and PCr in Slc6a8xY389C/y KI males compared to those of WT ones. Concentra-
tion of Cr and PCr in Slc6a8xY389C/y KI males was 70–75% less than that of WT in every brain region that was 
measured (Fig. 2B). These measures by 1H-MRS validate our Slc6a8Y389C rat model as brain Cr deficient and 
therefore as a valuable model to study CTD.
Lack of functional creatine transporter in Slc6a8Y389C rat males. CTD patients show an increased 
Cr/Crn ratio in urine due to the deficiency in functional Cr transporter present on kidney proximal tubular cells 
(which normally allows the reuptake of Cr from primary urine). We thus measured Cr and Crn in the urine of 
our Slc6a8Y389C rats to further validate our model as Cr transporter-deficient. Slc6a8xY389C/y KI males showed a 
very strong significant urinary increase of Cr/Crn ratio (8149 vs 31 mmol/mol, p = 0.0012, Fig. 2C), thus vali-
dating the loss of function of the Cr transporter in our Slc6a8Y389C model. This increase is due to a significant 
increase of Cr (9535 vs 278 µmol/l, p = 0.0012) and a significant decrease of Crn (1.23 vs 7.34 mmol/l, p = 0.0035). 
We also measured GAA in urine, and show, very interestingly, that GAA/Crn ratio was also strongly and sig-
nificantly elevated in Slc6a8xY389C/y KI males (1118 vs 84 mmol/mol, p = 0.0012; Fig. 2D), although no significant 
changes were found in urinary GAA levels (1289 vs 618 µmol/l, p = 0.097).
Slc6a8Y389C rat males present a decrease of Cr and an increase of GAA levels in plasma. We 
collected plasma and CSF from WT and Slc6a8xY389C/y KI males at around 3 months of age to see whether Cr 
and GAA concentrations were altered. We show a significant decrease of Cr and a significant increase of GAA 
concentrations in plasma of KI males in comparison to those of WT males (Fig. 3A left and right panels, respec-
tively). Cr and GAA levels in CSF from Slc6a8xY389C/y KI males at around 3 months of age showed no differences 
in comparison to those of WT males, with extremely low ranges for GAA (0.00 – 0.03 µmol/l) (Fig. 3B).
Slc6a8Y389C rat weight gain is slowed. KI males (Slc6a8xY389C/y) presented a significant reduced body 
weight gain just after weaning, as compared to WT males, showing for instance 56% of the body weight of their 
WT littermates at 14 weeks of age (312.7 ± 8.6 g vs 524.6 ± 12.1 g, p < 0.001, Mann–Whitney test) (Fig. 4).
Other brain metabolic changes in Slc6a8Y389C rats. As described above, Slc6a8Y389C rats showed brain 
Cr deficiency demonstrated by 1H-MRS in every CNS region measured (Fig. 2A, B). We further took advantage of 
our high resolution 9.4 T 1H-MRS measures to quantify potential metabolic changes in the brain of Slc6a8xY389C/y 
KI males. Interestingly, Gln, NAA, and the sum of NAA and NAAG (NAA + NAAG) concentrations were sig-
nificantly increased in all the brain regions analyzed while other metabolites changed their levels only in specific 
brain regions (Fig. 5A, B). In hippocampus, GABA, Glu, Tau and total choline (GPC + PCho) were significantly 
increased. In striatum, Ins increased while Lac decreased significantly. Interestingly, Ins tended to change in all 
brain regions although in different directions (Fig. 5B).
CTD patients present cognitive deficiency and behavioral troubles such as autistic-like behaviors or attention 
deficits. In order to analyze if our Slc6a8Y389C rat line is a good model for neurological symptoms of CTD, we 
performed several behavioral tests in relation with those symptoms.
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Figure 2.  Brain creatine deficiency and renal creatine transporter deficiency in Slc6a8xY389C/y KI males. 
(A) Representative 9.4 T 1H-MRS spectra in the hippocampus of WT and Slc6a8Y389C KI rats, showing the 
strong decrease of the Cr and PCr peaks in Slc6a8Y389C KI rats. Note the much smaller Cr and PCr peaks in 
KI male. The localization of the measured voxel is presented on top of the panel. (B) Box plots of Cr and PCr 
concentrations in hippocampus (Hp), striatum (St) and cerebellum (Cb) in WT and Slc6a8Y389C KI males (black 
and orange boxplots, respectively). 3–4 WT and 4–5 KI animals. (C) Cr/Crn and (D) GAA/Crn ratios in the 
urine of WT and Slc6a8xY389C/y KI males. 6 WT and 7 KI males. *: p < 0.05, **: p < 0.01, ***: p < 0.001 (two tail 
t-test for 1H-MRS; Mann–Whitney test for urine analysis). Statistical analysis was conducted with R-3.5.128. 
Graphs were done using ggplot2  package30.
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Figure 3.  Cr deficiency and GAA increase in plasma, while no change in CSF, in Slc6a8Y389C rats. (A) Box plot 
of Cr and GAA concentrations (left and right panel, respectively) of plasma in WT (black) and KI (orange) 
males. Note the reduction in Cr and the increase in GAA levels. (B) Box plot of Cr and GAA concentrations of 
CSF in WT and KI males. 6 WT and 7 KI males; **: p < 0.01, ***: p < 0.001, n.s. : no statistical differences (two-
tail t-test). Statistical analysis was conducted with R-3.5.128. Graphs were done using ggplot2  package30.
Figure 4.  Slc6a8Y389C KI males show a significantly decreased body weight gain. (A) Weight average (in grams) 
from 4 to 17 weeks of age. Error bars represent standard deviation. 13 animals per group, p < 0.0025 from 
4 weeks-old on (Mann–Whitney test). (B) Body size comparison between a WT and a KI male at 20 weeks of 
age. Gray rectangle dimension is 280 × 190 mm. Statistical analysis was conducted with R-3.5.128. Graphs were 
done using ggplot2  package30.
Figure 5.  Slc6a8Y389C KI males present a systematic and significant increase in Gln, NAA and NAA + NAAG 
levels in all brain regions. (A) Logarithm  (Log10) of concentration (in mmol/l) of 1H-MRS-measured metabolites 
in cerebellum (Cb), hippocampus (Hp) and striatum (St) from WT and KI males. (B) Logarithm of the KI 
concentrations normalized to WT (logarithm of the ratio between KI and WT concentrations). Blue colors 
indicate a reduction and red colors indicate an increase of concentrations with respect to the WT values. 3–4 
WT and 4–5 KI animals; p < 0.10; *p < 0.05; **p < 0.01, ***p < 0.001 (two-tail t-tests except for GABA in Cb, 
NAA + NAAG in Hp and PE in St, in which Mann–Whitney tests were used). Statistical analysis was conducted 
with R-3.5.128. Heatmaps were generated using  gplots31.
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Slc6a8xY389C/y KI males show similar performance to WT ones on NOR and Y‑maze for spatial 
memory tasks. To assess cognitive deficiency-like symptoms, we evaluated learning and memory perfor-
mance in two different tasks. Y-maze for spatial memory test evaluates short-term spatial memory while Novel 
Object Recognition (NOR) test measures declarative memory. In Y-maze for spatial memory, both recognition 
index and total exploration time of the arms were similar between genotypes (Fig. 6A). In NOR, Slc6a8xY389C/y 
KI males showed similar recognition index than WT littermates, although total exploration time of the objects 
was slightly higher in the testing phase (Fig. 6B) and significantly higher in the learning phase (+ 16% from 
WT, p = 0.043). Similar results were obtained when analyzing cumulative exploration times and recognition 
index every 30 s from the beginning (Supplementary Figure 1). This increase in exploration time without any 
improvement in learning and memory performance may indicate attention deficits and/or impairment in work-
ing memory capacity.
Slc6a8xY389C/y KI males present deficits in working memory. Working memory affects learning and 
 memory33. Additionally, to assess attention deficit in rodents, a task evaluating working memory is typically 
used. Thus, we carried out Y-maze for spontaneous alternation test in a different cohort of animals. Percentage 
of alternation index was used to compare working memory performance between genotypes and each genotype 
with the value of a random exploration (33.3% of alternation). While there were no differences in the number of 
entries between genotypes, the percentage of alternation for Slc6a8xY389C/y KI males was significantly reduced in 
comparison with that of WT males, having similar value than the expected by chance (Fig. 7A). This result shows 
impaired working memory in KI males.
Slc6a8xY389C/y KI males present more repetitive self‑stimulating behavior. To analyze whether 
Slc6a8xY389C/y KI males present autistic-like behavior, we decided to evaluate the presence of repetitive self-stim-
ulating behaviors like grooming. In a period of 10 min in an open field, KI males spent significantly more time 
doing grooming than WT males, and with higher frequency (Fig. 7B).
Slc6a8xY389C/y KI males show a tendency in decreased sociability. Decreased sociability is one core 
feature of autism spectrum disorders. We used Social Preference test (SP) to evaluate the general sociability 
and Social Memory test (SM) to evaluate the interest in social novelty. For this analysis, we used the cumulative 
duration of the rat exploring an item (juvenile, object, new or familiar juvenile, Fig. 8A, B), the number of the 
visits for each item (frequency, Fig. 8C) and the decision of the animals on what item was explored at the first 
place (Fig. 8D). As expected, WT males presented a significant preference for the juvenile in the SP paradigm, 
by showing significantly more time exploring the juvenile instead of the object (p < 0.001 two-tail t-test, Fig. 8A 
black boxplots). Slc6a8xY389C/y KI males also showed social preference over the object (p < 0.001 two-tail t-test, 
Fig. 8A orange boxplots), although spending a little less time with the juveniles in comparison with their WT 
littermates.
Looking at the two phases together, Slc6a8xY389C/y KI males systematically presented a tendency in reduc-
ing the cumulative duration exploring the juveniles (around − 17.5% less than WT males) but not the object 
(+ 7.6%). These little changes of KI males resulted in a nearly significant reduction of the social exploration time 
along the two phases (Fig. 8B, p = 0.051 two-tail t-test). Furthermore, the number of visits of KI rats towards 
the juveniles across the two phases was in general significantly lower than those of WT littermates but similar 
towards the object (Fig. 8C). As expected, we also observed that there were more WT animals going to explore 
firstly the juvenile (7 out of 9) instead of the object, being marginally significant with respect to the random 
expectation (p = 0.090 one-sided exact binomial test, Fig. 8D green panel). In contrast, a lower percentage of KI 
Figure 6.  Slc6a8xY389C/y KI males did not present differences in Y-maze (spatial memory) or NOR (declarative 
memory). A: Y-maze test showed no differences between genotypes in recognition index (left panel, p = 0.94) or 
total exploration time of both arms (right panel, p = 0.80). B: NOR test recognition index was similar between 
genotypes (left panel, p = 0.97), although total exploration time (in seconds) was slightly higher in KI males 
(right panel, p = 0.064). 9 WT + 9 KI males were used for Y-maze test, 9 WT + 9 KI for NOR test; p values were 
estimated with two-tail t-tests. n.s.: not significant. Statistical analysis was conducted with R-3.5.128. Graphs were 
done using ggplot2  package30.
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animals decided to visit the juvenile in the first place (7 out of 11), being not significantly higher than the number 
expected by chance (p = 0.27 one-sided exact binomial test, Fig. 8D green panel). In summary, Slc6a8xY389C/y KI 
males presented social preference but with a systematic pattern of reduced sociability when compared to their 
WT littermates.
Regarding the social novelty paradigm, WT and Slc6a8xY389C/y KI males spent similar time with the new and 
the familiar juveniles, showing no differences between the two genotypes (Fig. 8A). Interestingly, while the 
Figure 7.  Slc6a8xY389C/y KI males showed impaired working memory in Y-maze for spontaneous alternation, 
and more grooming behavior. A: Boxplots from Y-maze for spontaneous alternation test. WT and KI males 
had no differences in the number of entries (left panel, p = 0.57). KI males showed a significant reduction in % 
of alternations when compared with WT littermates (right panel, p = 0.039), being not higher than the value 
expected by chance (p = 0.39 one-tail t-test) while % of alternations in WT males were significantly higher 
(p = 0.010 one-tail t-test). (B) KI males showed more time doing grooming (left panel, p = 0.044) and with more 
frequency than WT littermates (right panel, p = 0.028, Mann–Whitney test). 8 WT and 10 KI males were used 
for Y-maze for spontaneous alternations, 10 WT and 10 KI for grooming behavior. By default, p-values were 
estimated with two-tail t-test. n.s.: not significant; *: p < 0.05. Statistical analysis was conducted with R-3.5.128. 
Graphs were done using ggplot2  package30.
Figure 8.  Slc6a8xY389C/y KI males show a systematic tendency in decreased sociability. (A) Total exploration 
time (in seconds) for each item from WT and KI males (black and orange boxplots, respectively). Note that both 
WT and KI males explored significantly more the juvenile than the object in the social preference phase. Note 
also the tendency (although no significant) of KI males, in comparison with their WT littermates, to take more 
time exploring the object and less time all juveniles in all phases of the test. (B) Sum of the total exploration 
time (in seconds) of all the juveniles in all the SP-SM test is strongly reduced in KI males. (C) Number of visits 
(frequency) to each item for WT and KI males. Note the general significant decrease in the number of visits 
towards the juveniles in KI males. P values in A–C were estimated with two-tail t-test. (D) Percentage of animals 
who went firstly to a certain item per each phase. In social preference, the number of WT males visiting the 
juvenile in the first place was marginally significant over the random expectation (dashed line, p = 0.090 one-
sided exact binomial test), while the number of KI males was reduced and near to the level expected by chance 
(p = 0.27 one-sided exact binomial test). In social memory phase, while WT males’ preference to visit firstly 
the new or the familiar juvenile was random (p = 1.00 two-sided exact binomial test), KI males tended to avoid 
the new juvenile in the first place (p = 0.23 two-sided exact binomial test). 9 WT + 10 KI for both SP and SM 
phases. Obj, Juv, Njuv and Fjuv: object, juvenile, new and familiar juveniles respectively. *: p < 0.05; ***: p < 0.001. 
Statistical analysis was conducted with R-3.5.128. Graphs were done using ggplot2  package30.
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number of WT males exploring firstly the new juvenile was similar than the number expected by chance (5 out 
of 9 rats, p = 1.00 two-sided exact binomial test, Fig. 8C yellow panel), the number of KI males tended to be lower 
(3 out of 11 rats, p = 0.23 two-sided exact binomial test). These data may point towards an aversion of KI males 
in establishing the first contact with a social novelty.
Discussion
We present here the first analysis of a new in vivo model of CTD, the Slc6a8Y389C knock-in rat holding an identical 
patient’s missense mutation abolishing CrT  activity17. Slc6a8xY389C/y KI rat males are brain creatine deficient, and 
exhibit increased Cr/Crn urine ratio as well as neurological symptoms similar to those of CTD patients, such as 
cognitive deficits and some autistic-like traits.
Using similar techniques as in the clinic, we first analyzed the brain metabolic profile of Slc6a8xY389C/y KI 
rat males by 1H-MRS to check whether they present the same pathognomonic signature as CTD patients. All 
the Slc6a8xY389C/y KI rat males analyzed showed the specific markers of CCDS and CTD: a strong reduction of 
Cr levels in the brain and a strong increase in urinary Cr/Crn  ratio17. These results validate the Slc6a8Y389C rat 
line as a plausible model of CTD, being the first model of ubiquitous CrT deficiency confirming the two known 
biochemical signatures of CTD.
The increase in urine Cr levels reveals a functional deficiency in the reuptake of Cr from the primary urine, 
which is normally done at the renal proximal tubular cells by  CrT34. Given that plasma Cr is being filtered and 
lost in the urine due to CrT deficiency, we could expect that Cr levels in plasma were diminished and those 
of GAA, the precursor of Cr, were increased in an attempt to compensate Cr levels by AGAT feedback loop of 
up-regulation due to Cr deficiency (for this mechanism in  periphery2,35,36 or for  CNS37). Indeed, a tendency to 
decreased Cr levels and significant increased GAA were observed in the plasma of Slc6a8xY389C/y KI males. This 
finding is in agreement with the decreased levels of Cr also observed in the ubiquitous KO mouse males with 
exons 2–4  deleted16. These data contrast however with the low number of patients with available measurements 
of Cr and GAA in plasma showing normal or mildly elevated Cr levels as well as normal GAA 7,17. Further studies 
are needed to unravel the possible causes of these differences between human and rodents.
Furthermore, we present the first measurement of the GAA/Crn ratio in urine of an in vivo CTD model. 
This ratio was strongly and significantly elevated in Slc6a8xY389C/y KI males, suggesting that GAA/Crn ratio in 
urine may also be a valid biochemical marker for CTD when is found together with increased Cr/Crn ratio. 
This result might help to bring attention towards a CTD diagnosis in patients with suspected GAMT-D (where 
increased GAA levels in urine are characteristic, although with a low or slightly low Cr/Crn  ratio7). New data 
from patients will help to confirm whether this double marker would be useful for CTD diagnosis. Whether 
GAA is also re-absorbed from primary urine in proximal tubular cells of kidney through transport by CrT (as we 
have shown in brain  cells38) remains to be determined. Indeed, while Cr was decreased in plasma and increased 
in urine of Slc6a8xY389C/y KI males demonstrating CrT deficiency, GAA was increased in plasma but normal with 
a tendency to increase in urine.
Consistent with CTD  patients17 and all the ubiquitous CrT KO mouse  models12,14,16, Slc6a8xY389C/y KI males 
presented lower body weight. We observed this difference already after weaning, but taking into account the 
degree of significance, it is likely that it extends from previous time points. This body weight gain issue is in 
agreement with reported early signs of  CTD39.
Although Cr levels in plasma and in brain were lower in Slc6a8xY389C/y KI males than in their WT littermates, 
Cr levels in the CSF were mildly higher or similar to those of WT ones. This is consistent with what was observed 
in CTD  patients7, confirming that CSF does not always reflect what is happening in brain parenchyma, and that 
CSF can also be a useful diagnostic sample for the differential diagnosis between CTD and GAMT deficiency, 
in which Cr is  decreased7. Interestingly, while WT males showed higher levels of Cr in plasma than in CSF, 
Slc6a8xY389C/y KI males exhibited similar levels in both liquids (60–70 µmol/l). Altogether, these data support 
the fact that the Cr pool in CNS does not fully depend on the peripheral one, owing to the low permeability of 
blood–brain barrier for Cr and to brain endogenous synthesis of  Cr9,38,40,41.
In every brain region analyzed, the strongly decreased Cr levels in brain parenchyma from Slc6a8xY389C/y KI 
males were accompanied by significant increases in Gln, NAA and NAA + NAAG. Given that these molecules are 
important osmolytes in  CNS42–44, and that the magnitudes of both changes tend to be similar, it might hint at an 
osmolyte compensation mechanism by Gln, NAA and/or NAAG for the brain Cr deficiency. Other metabolites 
with a role in osmoregulation are taurine, myo-inositol (Ins) or  choline45–47. Interestingly, the concentration of 
these metabolites change in some of the regions analyzed as well (see below). We have recently shown a similar 
potential mechanism of osmolytes compensation involving the same molecules in another pathological condi-
tion of CNS (hepatic  encephalopathy24). As Gln, NAA and NAAG play other important roles in CNS, a line for 
future research is to establish whether their changes only compensate Cr deficiency osmotically, or are truly 
pathological.
Other metabolites changed differentially depending on the brain region analyzed. In hippocampus, neuro-
transmitters such as GABA, Glu and Tau increased together with total choline, a precursor for another neuro-
transmitter (acetylcholine), membrane phospholipids and, (via betaine) the methyl group donor S-adenosylme-
thionine which is involved in the synthesis of Cr from GAA 48. Gln is a precursor for Glu, which is a precursor for 
GABA. Transporters for GABA and Tau can transport Cr or GAA 40. It would thus be possible that alterations in 
Cr and/or GAA levels might affect GABA and Tau homeostasis and their concentrations. As described above Tau 
and total choline in hippocampus might also participate to an osmolyte compensation mechanism under Cr defi-
ciency. Overall, these metabolic changes may suggest that endogenous Cr synthesis may also be affected, together 
with disturbances in neurotransmission in the hippocampus of Slc6a8xY389C/y KI males. Hippocampus is involved 
in motivation, emotion, learning and memory, and these changes could affect its functions and also promote 
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epilepsy in CTD patients. In striatum, Slc6a8xY389C/y KI males showed an increase in Ins, osmolyte also involved 
in many other cellular processes. The decrease in lactate might reflect a change in striatal energy metabolism.
These alterations in brain metabolites correlate with changes in behavior and cognition. In comparison with 
their WT littermates, Slc6a8xY389C/y KI males showed similar learning and memory performance in simple tasks 
about recognition and spatial memory (NOR and Y-maze for spatial memory tests) but failed in a working 
memory task (Y-maze for spontaneous alternation). Higher exploration times of objects in both phases of NOR 
test without any advantage in declarative memory might reflect a deficit in cognition related with attention and 
working memory as well. These negative results in learning and memory performance contrast with the data 
from the ubiquitous CrT KO mice with exons 2–4 and 5–7 deleted, where deficits were present although with 
milder phenotype in NOR test around the same age in the last  one13,16. Interestingly, these results showing nor-
mal recognition of an object or a location in KI males are aligned with data from CTD patients, as they are able 
to remember people, objects or locations but fail in the performance of more complex daily tasks and learning 
new  abilities17,39. Performance of tasks with little or high level of complexity/difficulty can also be influenced by 
emotional learning and memory, and by other cognitive processes such as language or attention. Whether all 
these cognitive processes are affected and how, and whether they are playing a role in the cognitive features of 
CTD pathology are still open questions to be addressed in the future.
On the other hand, working memory deficits of KI males are in agreement with the ubiquitous CrT KO with 
exons 5–7  deleted13 and with the presence of attention deficits observed in  patients17. However, not all CTD 
patients, including the one sharing the c.1166A < G; p.(Tyr389Cys) mutation with KI males, are diagnosed with 
attention  deficits17 (Van de Kamp personal communication). Interestingly, similar variability was present in 
the cohort of KI males in relation with working memory assessment, where although the average of the group 
showed significant reduction in the percentage of alternation, few animals presented values higher than the 
random expectation overlapping with the smallest values of WT males (see how the KI boxplot shifted down 
but still overlaps somehow the WT boxplot in Fig. 7A).
A lot of evidence about working memory supports the relationship with learning and memory  processes33 as 
well as the significant impact on the performance of daily  tasks49. Working memory capacity is a good predictor 
of learning  outcomes50 and general  intelligence51. Overall, our data may suggest that impairment in working 
memory, rather than deficits in declarative memory per se, is one of the primary components in the intellectual 
disability from CTD patients. Such hypothesis could open new avenues for alternative therapies to support 
working memory in order to improve learning in patients. Further studies are needed to address these questions.
Besides intellectual disability and attention deficits, autistic-like behavior is another common symptom in 
CTD patients. We evaluated the presence of two core features of autism spectrum disorder: repetitive self-stim-
ulating behaviors (like grooming for rats) and sociability. Slc6a8xY389C/y KI males spent significantly more time 
in grooming and with more frequency, consistent with another CTD  model13. Additionally, KI males appeared 
to be social but less than their WT littermates. This less social tendency is seen in the systematic pattern of 
spending less time with less frequency exploring the juveniles in all phases in contrast to exploring the object, 
and by having less tendency to first visit the juvenile instead of the object. Regarding the testing phase and in 
agreement with previous  works52, WT males explored equally the new and the familiar juveniles, showing no 
preference to first visit any of the juveniles when the interval between phases was 2 h. KI males spent similar time 
exploring the new and the familiar juveniles, although they showed slightly more preference towards visiting 
the familiar juvenile in the first place. This result might reflect an aversion to establish the first contact with a 
social novelty, which is another feature of sociability present in autism. Given the 2 h interval and the tendency 
to explore less the juveniles, whether KI males present differences in social memory or not in comparison with 
their WT littermates is not conclusive. Overall, these results of KI males (increased repetitive self-stimulating 
behavior, a systematic tendency in reducing sociability, including the bias trend of avoiding a social novelty) are 
in line with the autistic phenotype of the CTD patient sharing the same missense mutation as Slc6a8xY389C/y KI 
 males17 (Van de Kamp, personal communication). Importantly, the Slc6a8Y389C rat line is the first animal model 
of CTD showing a difference in sociability. Further studies will be needed to unravel the nature of this difference.
In summary, this new Slc6a8Y389C rat line is the first CTD model generated so far with one of the single nucleo-
tide mutations described in CTD patients. Slc6a8xY389C/y male rats present characteristic features of CTD pathol-
ogy and reveal the Slc6a8Y389C rat line as a valuable model of CTD, fairly enriching the spectrum of in vivo CTD 
models. Additionally, we have shown new data confirming what has been shown in patients and highlighting 
common aspects of CTD pathology. Future work will aim at further characterizing the molecular mechanism and 
the consequences of CTD in the Slc6a8Y389C rat line both in periphery and in CNS. Recent work demonstrated that 
several variants of CrT are expressed although misfolded, some of them being rescued with chemical chaperones 
thus opening new avenues for the treatment of CTD  patients53,54. Using the Slc6a8Y389C rat line to develop new 
strategies of treatment for CTD, this chaperone approach will also be tested in this new in vivo model.
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